KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medtronic (MDT) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Medtronic (MDT) over the last 12 years, with Q4 2025 value amounting to -$8.1 billion.

  • Medtronic's Enterprise Value fell 458.35% to -$8.1 billion in Q4 2025 from the same period last year, while for Oct 2025 it was -$8.1 billion, marking a year-over-year decrease of 458.35%. This contributed to the annual value of -$8.7 billion for FY2025, which is 1197.59% down from last year.
  • Per Medtronic's latest filing, its Enterprise Value stood at -$8.1 billion for Q4 2025, which was down 458.35% from -$7.9 billion recorded in Q3 2025.
  • Medtronic's 5-year Enterprise Value high stood at -$7.5 billion for Q4 2023, and its period low was -$14.5 billion during Q1 2021.
  • For the 5-year period, Medtronic's Enterprise Value averaged around -$9.3 billion, with its median value being -$8.4 billion (2022).
  • As far as peak fluctuations go, Medtronic's Enterprise Value tumbled by 2600.37% in 2021, and later skyrocketed by 3293.34% in 2023.
  • Quarter analysis of 5 years shows Medtronic's Enterprise Value stood at -$10.5 billion in 2021, then fell by 7.16% to -$11.3 billion in 2022, then soared by 32.93% to -$7.5 billion in 2023, then fell by 2.92% to -$7.8 billion in 2024, then dropped by 4.58% to -$8.1 billion in 2025.
  • Its Enterprise Value was -$8.1 billion in Q4 2025, compared to -$7.9 billion in Q3 2025 and -$8.7 billion in Q2 2025.